New UK trial looks to reduce COVID-19 drug development to a few weeks

The new UK trial initiative aims to cut the design phase of clinical studies for potential COVID-19 drugs from around 18 months to a few weeks. The ACCORD-2 collaboration will examine the effectiveness of repurposed medicines, potential new drugs, and currently unlicensed therapies in treating COVID-19 patients. Drug compounds that demonstrate effectiveness and safety in the early clinical trials stage

Continue Reading

Government backs new AI health projects in the UK

UK government has backed five new centres for AI in health, which will be focusing on areas that includes pathology, radiology and imaging. Centres will be based in Leeds, Oxford, Coventry, Glasgow and London. Utilising £50m in funding, the new centres will bring together doctors, businesses and academics to collaborate on the development of products

Continue Reading

Google’s Alphabet Restructuring will Help Focus Attention on the Company’s Health Ventures

Google have dominated the tech news this week as it announced its plans to re-organise the company and sub divisions over the next coming months in order to create a more streamlined and leaner organisation. The technology titan has created an over-arching holding company (Alphabet), which Google and its various other companies will become subsidiaries

Continue Reading